Review of imaging solutions for integrated quantitative immunohistochemistry in the Pathology daily practice.
MGĂ Rojo, G Bueno… - Folia histochemica et …, 2009 - journals.viamedica.pl
Immunohistochemistry (IHC) plays an essential role in Pathology. In order to improve
reproducibility and standardization of the results interpretation, IHC quantification methods …
reproducibility and standardization of the results interpretation, IHC quantification methods …
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists …
Purpose To update the American Society of Clinical Oncology (ASCO)/College of American
Pathologists (CAP) guideline recommendations for human epidermal growth factor receptor …
Pathologists (CAP) guideline recommendations for human epidermal growth factor receptor …
ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67
VJ Tuominen, S Ruotoistenmäki, A Viitanen… - Breast cancer …, 2010 - Springer
Introduction Accurate assessment of estrogen receptor (ER), progesterone receptor (PR),
and Ki-67 is essential in the histopathologic diagnostics of breast cancer. Commercially …
and Ki-67 is essential in the histopathologic diagnostics of breast cancer. Commercially …
Computer-aided techniques for chromogenic immunohistochemistry: status and directions
Although immunohistochemistry (IHC) is a popular imaging technique, the quantitative
analysis of IHC images via computer-aided methods is an emerging field that is gaining …
analysis of IHC images via computer-aided methods is an emerging field that is gaining …
Automatic image segmentation of nuclear stained breast tissue sections using color active contour model and an improved watershed method
Automatic image segmentation of immunohistologically stained breast tissue sections helps
pathologists to discover the cancer disease earlier. The detection of the real number of …
pathologists to discover the cancer disease earlier. The detection of the real number of …
Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure
AR Peck, AK Witkiewicz, C Liu, GA Stringer… - Journal of clinical …, 2011 - ascopubs.org
Purpose To investigate nuclear localized and tyrosine phosphorylated Stat5 (Nuc-pYStat5)
as a marker of prognosis in node-negative breast cancer and as a predictor of response to …
as a marker of prognosis in node-negative breast cancer and as a predictor of response to …
Fast unsupervised nuclear segmentation and classification scheme for automatic allred cancer scoring in immunohistochemical breast tissue images
Background and objective This paper presents an improved scheme able to perform
accurate segmentation and classification of cancer nuclei in immunohistochemical (IHC) …
accurate segmentation and classification of cancer nuclei in immunohistochemical (IHC) …
Reproducible quantification of biomarker expression
J Christiansen, R Pinard, M Gustavson… - US Patent …, 2016 - Google Patents
A method is described for the reproducible quantification of biomarker expression, including
biomarker expression in a tissue sample. Methods and systems are described whereby …
biomarker expression in a tissue sample. Methods and systems are described whereby …
Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ
Estrogens play essential roles in the progression of mammary and prostatic diseases. The
transcriptional effects of estrogens are transduced by two estrogen receptors, ERα and ERβ …
transcriptional effects of estrogens are transduced by two estrogen receptors, ERα and ERβ …
Standardization of HER2 immunohistochemistry in breast cancer by automated quantitative analysis
MD Gustavson, B Bourke-Martin… - … of pathology & …, 2009 - meridian.allenpress.com
Context.—There is critical need for standardization of HER2 immunohistochemistry testing in
the clinical laboratory setting. Recently, the American Society of Clinical Oncology and the …
the clinical laboratory setting. Recently, the American Society of Clinical Oncology and the …